ACSL1, ACSL3, ACSL4, and ACSL5 are expressed in primary myeloma cells and supportive of myeloma cell fitness, suggesting that broad targeting of the ACSLs could be impactful for MM patients. Here, ACSL3 is linked to plasma cell myeloma.